Literature DB >> 3427268

Interactions of amiodarone with digoxin in rats.

J Braunschweig1, M Stäubli, H Studer.   

Abstract

1. The influence of oral amiodarone treatment on the blood and tissue concentrations of digoxin was investigated in the anaesthetized rat by use of unlabelled and [3H]-digoxin. 2. Amiodarone diminished the total body clearance and the apparent volume of digoxin distribution by 60%. This reduction was due to a 50% reduction of the hepatobiliary clearance, whereas the renal clearance did not change. 3. Amiodarone treatment increased blood, myocardial and skeletal muscle [3H]-digoxin concentrations by 200% indicating passive equilibration between blood and these tissues, and resulting in unaltered tissue to blood ratios. In contrast, the liver concentration increased by 70% only and the liver to blood ratio therefore decreased under amiodarone treatment. 4. It is concluded that the hepatobiliary elimination of digoxin is decreased in amiodarone-treated rats compared to controls and is responsible for the increased levels of blood and tissue glycoside.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3427268      PMCID: PMC1853693          DOI: 10.1111/j.1476-5381.1987.tb11356.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Quantitative analysis of digoxin, 4'''-acetyldigoxin and 4'''-methyldigoxin and their metabolites in bile and urine of rats.

Authors:  K von Bergmann; U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

2.  Digoxin toxicity associated with amiodarone therapy in children.

Authors:  G Koren; P S Hesslein; S M MacLeod
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

3.  [Cardiac glycosides and metabolites--problems of recovery in tissue extracts. Separation of visible substance spots in the nanogram range (author's transl)].

Authors:  R Aderjan; S Doster; H Petri; G Schmidt
Journal:  Z Rechtsmed       Date:  1979-08

4.  Digoxin-amiodarone interaction: in vivo and in vitro studies in rats.

Authors:  G Koren; S Soldin; S M Macleod
Journal:  Can J Physiol Pharmacol       Date:  1983-12       Impact factor: 2.273

5.  Depressive effect of amiodarone on hepatic drug metabolism in the rat.

Authors:  O Grech-Bélanger
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-04

6.  Digoxin and metabolites in urine and feces: a fluorescence derivatization--high-performance liquid chromatographic technique.

Authors:  T A Shepard; J Hui; A Chandrasekaran; R A Sams; R H Reuning; L W Robertson; J H Caldwell; R L Donnerberg
Journal:  J Chromatogr       Date:  1986-07-11

7.  Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications.

Authors:  K Nademanee; R Kannan; J Hendrickson; M Ookhtens; I Kay; B N Singh
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

8.  Amiodarone-digoxin interaction. Clinical and experimental observations.

Authors:  W J Oetgen; S M Sobol; T B Tri; W H Heydorn; L Rakita
Journal:  Chest       Date:  1984-07       Impact factor: 9.410

9.  Amiodarone and amiodarone plus digitalis in the treatment of paroxismal supraventricular reciprocating tachyarrhythmias.

Authors:  F Furlanello; G Inama; M Ferrari; R Padrini; D Piovan; M Guarnerio; G Vergara; A Del Favero; P Dal Forno; M Disertori
Journal:  Pharmacol Res Commun       Date:  1982-09

10.  Pharmacokinetic evaluation of the digoxin-amiodarone interaction.

Authors:  P E Fenster; N W White; C D Hanson
Journal:  J Am Coll Cardiol       Date:  1985-01       Impact factor: 24.094

View more
  1 in total

1.  Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver.

Authors:  Takaaki Kodawara; Satohiro Masuda; Hiroko Wakasugi; Yuichi Uwai; Takahiro Futami; Hideyuki Saito; Takaaki Abe; Ken-ichi Inu
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.